LIVE SEC EDGAR FORM 4 INGESTION

Recent Insider Trading Activity

Real-time feed of open-market stock purchases and sales by corporate executives, directors, and 10% beneficial owners verified against official SEC Form 4 filings.

donut_large Market-Wide Insider Flow & Volume Breakdown

Real-time aggregate capital distribution across parsed SEC Form 4 filings
trending_down Net Insider Flow
▼ Net Outflow
▼ -$13.61M Net Flow
↗
Buys (Inflow) $0 (0.0%)
$0M open-market purchases
↘
Sells (Outflow) $13.61M (100.0%)
$13.6M open-market sales
pie_chart Buy / Sell Ratio
0.0% Buy Bias
▼ 0.0% Buys
↗
Purchases 0 trades (0.0%)
Discretionary capital accumulation
↘
Sales 24 trades (100.0%)
Executive liquidation transactions
workspace_premium Top Conviction Buy
🐋 Whale Trade
U
U
Unity Software Inc.
$48.27M
By BOYDEN REBECCA BERENIC… Officer
analytics Analyze query_stats Backtest
Quick Presets: all_inclusive All Trades 🐋 Whale Buys ($1M+) 👔 C-Suite Buys (CEO/CFO) 💎 Significant Buys ($100k+) ⚡ Last 24 Hours 🚨 Major Insider Sales
filter_alt Filter Insider Filings
Open Market Transactions Only
refresh
Popular Tickers: WMT UTHR TH TELA TK SONY SKYE SMTC
table_chart

Live SEC Form 4 Transactions Stream

Showing 24 of 24 entries
Recency Stock Insider Role Type Shares Price Total Value SEC Form 4 Actions
3d ago 2026-09-18
UTHR
UNITED THERAPEUTICS Corp
MAHON PAUL A EVP & GENERAL COUNSEL arrow_downward SELL -320 $501.58 $160.5K open_in_new Form 4
3d ago 2026-09-18
UTHR
UNITED THERAPEUTICS Corp
MAHON PAUL A EVP & GENERAL COUNSEL arrow_downward SELL -125 $500.80 $62.6K open_in_new Form 4
3d ago 2026-09-18
UTHR
UNITED THERAPEUTICS Corp
MAHON PAUL A EVP & GENERAL COUNSEL arrow_downward SELL -1,160 $499.75 $579.7K open_in_new Form 4
3d ago 2026-09-18
UTHR
UNITED THERAPEUTICS Corp
MAHON PAUL A EVP & GENERAL COUNSEL arrow_downward SELL -843 $498.74 $420.4K open_in_new Form 4
3d ago 2026-09-18
UTHR
UNITED THERAPEUTICS Corp
MAHON PAUL A EVP & GENERAL COUNSEL arrow_downward SELL -1,400 $497.54 $696.6K open_in_new Form 4
3d ago 2026-09-18
UTHR
UTHR 🐋 Whale
UNITED THERAPEUTICS Corp
MAHON PAUL A EVP & GENERAL COUNSEL arrow_downward SELL -2,873 $496.58 $1.43M open_in_new Form 4
3d ago 2026-09-18
UTHR
UNITED THERAPEUTICS Corp
MAHON PAUL A EVP & GENERAL COUNSEL arrow_downward SELL -1,579 $495.97 $783.1K open_in_new Form 4
3d ago 2026-09-18
UTHR
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A CEO arrow_downward SELL -160 $501.60 $80.3K open_in_new Form 4
3d ago 2026-09-18
UTHR
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A CEO arrow_downward SELL -468 $500.09 $234.0K open_in_new Form 4
3d ago 2026-09-18
UTHR
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A CEO arrow_downward SELL -332 $499.10 $165.7K open_in_new Form 4
3d ago 2026-09-18
UTHR
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A CEO arrow_downward SELL -151 $497.79 $75.2K open_in_new Form 4
3d ago 2026-09-18
UTHR
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A CEO arrow_downward SELL -1,953 $497.17 $971.0K open_in_new Form 4
3d ago 2026-09-18
UTHR
UTHR 🐋 Whale
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A CEO arrow_downward SELL -2,182 $496.21 $1.08M open_in_new Form 4
3d ago 2026-09-18
UTHR
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A CEO arrow_downward SELL -1,905 $495.11 $943.2K open_in_new Form 4
3d ago 2026-09-18
UTHR
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A CEO arrow_downward SELL -1,750 $494.34 $865.1K open_in_new Form 4
3d ago 2026-09-18
UTHR
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A CEO arrow_downward SELL -599 $493.22 $295.4K open_in_new Form 4
4d ago 2026-09-17
UTHR
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A CEO arrow_downward SELL -120 $505.20 $60.6K open_in_new Form 4
4d ago 2026-09-17
UTHR
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A CEO arrow_downward SELL -1,182 $504.17 $595.9K open_in_new Form 4
4d ago 2026-09-17
UTHR
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A CEO arrow_downward SELL -1,538 $503.53 $774.4K open_in_new Form 4
4d ago 2026-09-17
UTHR
UTHR 🐋 Whale
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A CEO arrow_downward SELL -2,160 $502.44 $1.09M open_in_new Form 4
4d ago 2026-09-17
UTHR
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A CEO arrow_downward SELL -708 $501.52 $355.1K open_in_new Form 4
4d ago 2026-09-17
UTHR
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A CEO arrow_downward SELL -492 $500.19 $246.1K open_in_new Form 4
4d ago 2026-09-17
UTHR
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A CEO arrow_downward SELL -1,220 $499.15 $609.0K open_in_new Form 4
4d ago 2026-09-17
UTHR
UTHR 🐋 Whale
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A CEO arrow_downward SELL -2,080 $498.45 $1.04M open_in_new Form 4
Showing page 1 of 1 (24 total filings)
menu_book

SEC Form 4 Trading Guide & Transaction Code Matrix

Securities Exchange Act Section 16(a)

Under Section 16(a) of the Securities Exchange Act of 1934, corporate insiders—executives, directors, and beneficial owners holding greater than 10% of any registered equity class—must report changes in stock ownership within two business days. Not all filings carry equal predictive value. Tickzen automatically categorizes transactions using the official SEC Table I code matrix:

SEC Code Transaction Type Capital Outlay Signal Direction Predictive Significance & Institutional Rationale
Code P Open-Market Purchase Discretionary (Personal Cash) ▲ High Bullish The insider commits their own capital to buy shares at current market prices. Strongest positive conviction signal.
Code S Open-Market Sale Discretionary (Disposition) ▼ Variable / Caution Discretionary disposition of shares. Often executed for tax planning, estate diversification, or pre-set Rule 10b5-1 plans; heavy clustered selling warrants caution.
Code A Grant or Award Non-Discretionary (Equity Comp) ● Neutral Restricted Stock Units (RSUs) or performance shares granted by compensation committees. Reflects compensation, not independent buying.
Code M Option Exercise Contractual Conversion ● Neutral / Plan Conversion of stock options into shares, commonly paired with an immediate cashless open-market sale (Code S) to pay exercise fees and taxes.
Code F Tax Withholding Mandatory Administrative ● Neutral Automatic surrender of shares to the issuing company to pay statutory income tax liabilities upon equity vesting.
Code G Bona Fide Gift Non-Market Transfer ● Neutral Charitable contribution or private transfer of shares to family trusts, non-profit institutions, or estate planning vehicles.
hub

Cluster Buying Dynamics

When 3 or more distinct corporate insiders purchase company stock within a 10-day window, academic studies show a statistically significant abnormal return over the subsequent 3 to 12 months compared to solitary executive purchases.

badge

C-Suite vs. 10% Beneficial Owners

Chief Executive Officers (CEO) and Chief Financial Officers (CFO) possess daily operational oversight of sales pipelines and cost structures. Their discretionary purchases carry a much higher predictive signal than passive 10% hedge fund allocations.

quiz Frequently Asked Questions About SEC Form 4 & Insider Trading

Verified answers regarding filing rules, transaction codes, and legal requirements
SEC Form 4 is a mandatory statement of changes in beneficial ownership filed with the United States Securities and Exchange Commission (SEC) under Section 16(a) of the Securities Exchange Act of 1934. Corporate insiders—defined as directors, officers (such as CEOs and CFOs), and beneficial owners holding greater than 10% of a company's equity—must file Form 4 within two business days of completing any transaction in their company's securities.
In SEC Form 4 Table I, Transaction Code P designates an open-market or private purchase of securities, indicating that an insider committed personal capital to acquire shares at prevailing market prices. Transaction Code S designates an open-market sale, where an insider disposed of shares. Code P purchases are widely considered by financial analysts to be high-conviction bullish signals, whereas Code S sales may occur for routine diversification, tax, or estate planning purposes.
Cluster buying occurs when three or more distinct corporate insiders (e.g., the CEO, CFO, and independent board directors) purchase shares of their own company's stock within a narrow timeframe (typically 5 to 10 trading sessions). Empirical financial research demonstrates that cluster purchases carry significantly higher predictive alpha than isolated single-officer buys, signaling strong collective confidence across the leadership team.
Yes, insider buying and selling is completely legal when executives, directors, and 10% owners trade during approved open window periods (such as after quarterly earnings disclosures) and comply with SEC Rule 10b5-1 pre-scheduled trading plans. These transactions become public record when disclosed to the SEC on Form 4 within 2 business days. Illegal insider trading, by contrast, involves trading on material non-public information (MNPI) prior to public disclosure.
Tickzen ingests Form 4 filings directly from the SEC EDGAR system continuously every 5 to 10 minutes throughout market hours and extended filing windows. Each filing is parsed in real time to filter out non-discretionary equity grants (Code A) and option exercises (Code M), isolating pure open-market discretionary transactions.